Peptide LexiconAll compounds

Peptidoglycan: The Bacterial Cell Wall Made of Sugars and Short Peptides — Not a Supplement

Peptidoglycan is the mesh that forms the cell wall of most bacteria: long sugar strands cross-linked by short peptides into one closed bag around the cell. It is not a peptide product and nobody takes it. It matters to medicine because penicillin-type antibiotics block its construction and the body's lysozyme breaks it down.

Made by bacteria, not by peopleA sugar-and-peptide mesh, not a single moleculeNot a medicine or supplement

Caroline S · Published 2026-10-04

Length

Not a fixed length: one continuous mesh per bacterial cell, built from glycan (sugar) strands joined by short peptides of a few amino acids

Sequence

No single sequence — the peptide composition varies between bacterial species and even with growth conditions (Vollmer et al., FEMS Microbiol Rev 2008, PMID 18194336)

Origin

Built by bacteria as the essential structural layer of their cell wall, forming a closed, bag-shaped 'sacculus' around the cell membrane (Vollmer et al. 2008).

Last reviewed

2026-10-05

What is it good for?

Nothing as a product — no one takes it. Its importance is as a target: it holds most bacteria together, penicillin-type antibiotics act by blocking its construction (the penicillin G label calls it cell-wall mucopeptide), and the body's own enzyme lysozyme is bacteriolytic.

Illustration: A clear glass beaker with pale green liquid on a chalk-white lab bench, deep green and copper reflections.
Illustration

What it is

Peptidoglycan is the cell wall of bacteria. A 2008 review by Vollmer, Blanot and de Pedro describes it as "a unique and essential structural element in the cell wall of most bacteria" (FEMS Microbiology Reviews, PMID 18194336). It has two ingredients, and its name lists both:

  • glycan — long strands of sugars;
  • peptide — short chains of a few amino acids that cross-link the strands.

Linked together, they form one continuous mesh, the sacculus, wrapped around the cell membrane like a closed bag. The peptides are not the same everywhere: the review records high diversity in their composition and sequence between species, and changes in the fine structure with growth conditions.

What the mesh is made of

A 2010 review of the bacterial envelope by Silhavy, Kahne and Walker (Cold Spring Harbor Perspectives in Biology, PMID 20452953) gives the building block: a repeating pair of sugars, N-acetylglucosamine and N-acetylmuramic acid, with pentapeptide side chains — five-amino-acid stems — that cross-link one strand to the next. The finished sacculus is, in the review's words, one very large polymer that can be isolated and seen under a light microscope. It is rigid enough to fix the cell's shape, and it is the reason bacteria do not burst when placed in distilled water.

Gram-positive and Gram-negative: a difference in thickness

In 1884 Christian Gram devised the stain that still sorts nearly all bacteria into two groups. The same review gives the structural reason it works:

Gram-negative Gram-positive
Peptidoglycan thickness A few nanometres 30–100 nm
Layers One to a few Many
Outside the wall An outer membrane containing lipopolysaccharide No outer membrane; long anionic polymers (teichoic acids) thread through the layers

The review adds that Gram-positive species differ among themselves most in the peptide cross-links between glycan strands — the same species-to-species variation the 2008 review describes.

Why it is not a supplement

This library mostly records peptides people take or are prescribed. Peptidoglycan is in it for the opposite reason: people search the word because it contains "peptide", and it is nothing of that kind. Humans do not make it, it is not sold as a product, and no approved medicine contains it. The peptide-chain entry and the peptide-bond entry explain the chemistry the two share — amino acids joined by peptide bonds — and nothing more.

Why it matters to medicine

Because people do not make peptidoglycan and most bacteria cannot live without it, its construction is a target:

Who acts on it What the source says
Penicillin G Acts by inhibiting biosynthesis of cell-wall mucopeptide — an older name for peptidoglycan (penicillin G potassium label, effective 2025-01-28)
Vancomycin Its bactericidal action results primarily from inhibition of cell-wall biosynthesis (vancomycin hydrochloride injection label, Gland Pharma, effective 2026-01-30)
Lysozyme (the body's own enzyme) A 148-residue human enzyme in tissues and body fluids, annotated as primarily bacteriolytic; its recorded reaction is hydrolysis of the (1→4)-beta links between N-acetylmuramic acid and N-acetylglucosamine in peptidoglycan, EC 3.2.1.17 — it cuts the sugar backbone, not the peptides (UniProt P61626)

A newer antibiotic in the same family as vancomycin is precise about the target: the lipoglycopeptide dalbavancin binds the D-alanyl-D-alanine end of the peptide stems and so blocks cross-linking (Dalvance label). The body's own antibacterial peptides, such as LL-37, are a separate line of defence and are recorded in their own entries.

Where it stands

PubMed returns 19,091 records for peptidoglycan, only 16 tagged as randomised controlled trials (2026-10-04) — a microbiology subject, not a treatment one. Physical measurements of its thickness, elasticity and porosity are, in the 2008 review's words, limited.

For what a peptide is and how short chains are named, see what peptides are. For the human antimicrobial peptide most often discussed online, see LL-37; for the cyclic peptide in over-the-counter first-aid ointment, see the bacitracin entry.

What the research shows

Forms the essential cell wall of most bacteria

Review of peptidoglycan structure: 'a unique and essential structural element in the cell wall of most bacteria' (Vollmer et al., FEMS Microbiol Rev 2008, PMID 18194336)

Is the target of penicillin

Penicillin G label: acts by inhibiting biosynthesis of cell-wall mucopeptide (penicillin G potassium label, effective 2025-01-28)

Has any use as a supplement or peptide product

None. It is a bacterial structure; no approved product or registered supplement use was found

Bars show how much of the evidence is in humans, not how well anything works.

Where it stands

What it is

A structural polymer of bacteria, not a hormone, drug or supplement.

United States

No product. Antibiotics that block its synthesis, such as penicillin G, are approved medicines.

Published record

PubMed returns 19,091 records for peptidoglycan, 16 tagged as randomised controlled trials (2026-10-04).

Frequently asked questions

What is peptidoglycan?

The material of the bacterial cell wall: long sugar (glycan) strands cross-linked by short peptides into a single mesh that surrounds the cell like a bag. It is also called murein.

Is peptidoglycan a peptide?

Partly. It contains short peptides, which is where the name comes from, but they are woven into a sugar mesh. It is a bacterial structure, not a peptide product of the kind discussed elsewhere in this library.

Do humans have peptidoglycan?

No. People do not make it; bacteria do. That difference is why drugs that block peptidoglycan construction can harm bacteria without targeting human cells in the same way.

What is the difference between Gram-positive and Gram-negative bacteria?

The thickness of the peptidoglycan wall. A 2010 review (Silhavy, Kahne and Walker, PMID 20452953) puts Gram-negative peptidoglycan at only a few nanometres, one to a few layers, under an outer membrane; Gram-positive peptidoglycan is 30–100 nm thick and has many layers. Christian Gram's 1884 stain separates the two groups by that structural difference.

How does lysozyme break down peptidoglycan?

UniProt records human lysozyme's catalytic activity as hydrolysis of the (1→4)-beta links between N-acetylmuramic acid and N-acetylglucosamine in peptidoglycan (enzyme class EC 3.2.1.17) — it cuts the sugar backbone, not the peptide cross-links.

How does penicillin affect peptidoglycan?

The penicillin G label states that it acts by inhibiting biosynthesis of cell-wall mucopeptide, an older name for peptidoglycan. A bacterium that cannot finish its wall cannot hold itself together as it grows.